{
  "id": 132707,
  "title": "J&J pharma leader to retire; Krystal slumps on gene therapy miss",
  "url": "https://urgent.news/2026/08/04/j-j-pharma-leader-to-retire-krystal-slumps-on-gene-therapy-miss",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-04T14:20:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/johnson-taubert-krystal-vyjuvek-merck-prometheus-pathos-pluvicto/826859/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Jennifer Taubert will step down after a lengthy run leading J&J’s pharmaceutical business. Elsewhere, pricing issues hampered what Wall Street analysts view as an otherwise strong gene therapy launch.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}